Human TRACP/PAP/ACP5 Antibody
R&D Systems, part of Bio-Techne | Catalog # MAB3948
Key Product Details
Species Reactivity
Validated:
Applications
Label
Antibody Source
Product Summary for Human TRACP/PAP/ACP5 Antibody
Immunogen
Ala22-Pro320
Accession # P13686
Specificity
Clonality
Host
Isotype
Applications for Human TRACP/PAP/ACP5 Antibody
Western Blot
Sample: Recombinant Human TRACP/PAP/ACP5 (Catalog # 3948-AP)
Formulation, Preparation, and Storage
Purification
Reconstitution
Formulation
Shipping
Stability & Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: TRACP/PAP/ACP5
Encoded by the ACP5 gene, Tartrate Resistant Acid Phosphatase (TRACP or TRAP) is also known as Purple Acid Phosphatase (PAP) or Acid Phosphatase 5 (ACP5) (1). The deuced amino acid (aa) sequence of human ACP5 predicts a signal peptide (aa 1-21) and a mature chain (aa 22-325). R&D Systems’ recombinant human ACP5 consists of aa 22-320, without the last 5 residues, RRARP.
ACP5 is expressed at high levels by osteoclasts, macrophages and dendritic cells (2). Two forms, 5a and 5b, circulating in human blood, are derived from different cell types and have different functions. Derived from macrophages and dendritic cells, 5a is a marker of inflammatory conditions. Derived from osteoclasts, 5b is a marker of bone resorption. Compared to 5a, 5b does not contain sialic acid residues, has a higher specific activity and pH optimum, and may be processed into a disulfide-linked dimer (3).
References
- Janckila, A.J. and J.M. Halleen (2003) J. Bone Miner. Res. 18:1892.
- Halleen, J.M. et al. (2006) Clin. Lab. 52:499.
- Janckila, A.J. et al. (2003) J. Bone Miner. Res. 18:1916.
Long Name
Alternate Names
Gene Symbol
UniProt
Additional TRACP/PAP/ACP5 Products
Product Documents for Human TRACP/PAP/ACP5 Antibody
Product Specific Notices for Human TRACP/PAP/ACP5 Antibody
For research use only